New Products and Industry News

Burn and wound care business acquired

  Mölnlycke Health Care US, LLC (Norcross, GA) acquired all the commercial assets of Brennen Medical (St. Paul, MN) within the burn and wound care markets. Under a new name, Brennen Medical will continue to develop their core technologies (porcine tissue and beta-glucans) for applications in other markets.

  For more information, visit, www.molnlycke.com.

Hydrofiber wound dressing now available in US

  ConvaTec’s (Skillman, NJ) AQUACEL® EXTRA™ wound dressing with strengthening fiber is now available in the United States. It is constructed with two-dimensional strengthening fibers stitched into the dressing. Although it is made from the same base material used to manufacture Hydrofiber® Technology, the strengthening fibers do not gel on contact with fluid, so they maintain their integrity and become encompassed by the gel, providing additional strength. The design makes it nine times stronger and increases absorbency 39% over the current AQUACEL® wound dressings. The new design also aids the easy removal from even the deepest wound beds. The new wound dressing will be specifically suitable when managing moderate to highly exuding wounds.   Dressings are available in three sizes: 2 inches x 2 inches (5 cm x 5 cm), 4 inches x 5 inches (10 cm x 12 cm) and 6 inches x 6 inches (15 cm x 15 cm).

  For more information, visit www.convatec.com.

Antimicrobial hydrogel with silver introduced

  Normlgel® Ag, the latest addition to Mölnlycke Health Care’s (Norcross, GA) antimicrobial dressing portfolio, is an antimicrobial hydrogel that contains a silver carbonate. This compound provides an effective barrier to bacterial penetration by inhibiting the growth of a broad spectrum of microorganisms that come into contact with the gel.

  The product is effective in assisting the debridement and desloughing process in dry necrotic wounds, while maintaining a moist wound environment for optimal wound healing. It is indicated for the management of dry to moderate exuding partial- and full-thickness chronic and acute wounds.

  For more information visit www.molnlycke.us.

One topical cream provides ostomy, wound care, and skin protection

  TapeRelief™ (Las Vegas, NV), a new topical cream that provides a soothing and effective barrier between human skin and medical tape and adhesives, can replace multiple products commonly used for wound care and skin protection. Regular use has proven to reduce or prevent numerous ailments arising from medical purpose adhesives intended to protect the patient.

  For more information, visit www.TapeRelief.com.

Antipruritic hydrogel reduces itch, pain, and burning

  Quinnova Pharmaceuticals (Petaluma, CA) launched the Atrapro™ family of products formulated from the Microcyn® Technology platform. The two products, Atrapro™Antipruritic Hydrogel (which reduces the itch, pain, and burning of various dermatoses) and Atrapro Dermal Spray with preservatives for wound care, are prescription products promoted to the US dermatology market. The hydrogel formulation has been the subject of numerous studies by a variety of US dermatologists.

  For more information, visit www.quinnova.com.

Lab offers range of tests, including wound dressings

  Keith Cutting, international key opinion leader and OWM Board member, is now clinical and business director of an independent laboratory testing facility, Perfectus Medical (Cheshire, UK). The facility offers a range of standard and in vitro tests. The company has experience in a range of microbiological assays including biofilm, biocide, antimicrobial, and antibiotic susceptibility testing. It also offers molecular identification assays, PCR-DGGE and gene sequencing, and physico/chemical testing of wound dressings and bandages.

  For more information, email support@perfectus-medical.com or visit www.perfectus-medical.com.

One-piece ostomy barrier introduced

  Inventor Gilbert L. Abrams and Urologist-in-Chief at Columbia University Medical Center Dr. Mitchell C. Benson have partnered with New York City entrepreneur and angel investor Owen W. Coleman to create The Benson Turtleneck Barrier LLC to market the ostomy barrier solution, the Benson TurtleneckTM Barrier.

  The Benson Turtleneck Barrier is fabricated from a one-piece mold that secures without adhesive or glue in contact with the stoma. Abrams, who has 50 years of experience as a plastics product and mold engineer, initiated work on his invention to help a cousin with a stoma post colon cancer treatment. After seeing how well the product worked for his cousin, Abrams introduced Dr. Benson to his invention. Dr. Benson received positive feedback from his own patients, and lent his name to the product.

  The team is planning to find a partner to bring this invention to the marketplace, potentially changing the landscape of the approximately $2 billion annual global ostomy market.

  For more information, visit www.BensonTurtlenecBarrier.com/.

NAFC names most innovative new product

  The National Association For Continence (NAFC) (Charleston, SC) presented the Most Innovative New Product award to Coloplast (Minneapolis, MN) for its new product, InterDry® Ag, a textile that helps reduce the risk of moisture-associated skin damage, most often diagnosed as intertriginous dermatitis (intertrigo).

  As moisture accumulates and remains trapped within skin folds, bacteria, fungal, and viral growth inevitably lead to intertrigo, and even skin breakdown and subsequent ulceration. Obese patients, as well as those with contractures, are most vulnerable.

  The award was announced in the 2011–2012 issue of DISCOVERIES®, a directory of the newest products and services for people living in the US with bladder and bowel control problems.

  For more information, visit www.us.coloplast.com.

  In related news, The National Association For Continence (NAFC) (Charleston, SC) published DISCOVERIES as an e-book. The book can be viewed, free-of-charge, on the NAFC’s website. The book can be purchased through the NAFC’s online store. DISCOVERIES® is a companion and supplement to the Resource Guide®, an exclusive and complete directory of products and services for US residents living with incontinence and related pelvic floor dysfunction.

  DISCOVERIES covers products released since publication of the latest Resource Guide. These products are commercially available, about to be launched, or represent a new technology whose product applications are yet defined but which have relevancy to this field. This is the fifth edition of DISCOVERIES.

  For more information, visit www.NAFC.org.

New executive vice president and CFO named

  RecoverCare LLC (Louisville, KY) appointed Brian Cousins as Executive Vice President, Operations and Supply Chain and Kelly G. Duncan as Chief Financial Officer (CFO).

  Before joining RecoverCare, Cousins served as Global Vice President — Manufacturing & Supply Chain for the Fluid Power Division of the Gates Corporation.

  Duncan served as CFO of Service Net Warranty, a multinational service contract administrator for Fortune 500 companies.

Wound specialist named Senior Director of Clinical Marketing

  Advanced BioHealing, Inc (San Diego, CA) appointed Cynthia A. Fleck, RN, BSN, ET/WOCN, CWS, CFCN, DNC, as Senior Director of Clinical Marketing.

  Fleck is a board-certified wound specialist and dermatology advanced practice nurse. She will be responsible for building clinical education and marketing programs throughout the US focused on the company’s lead product, DERMAGRAFT®, for diabetic foot ulcers.

  For more information, visit www.ABH.com.

Contract awarded for wound debridement and cleansing system

  IrriMax® Corporation, (Gainesville, FL), has been awarded a supplier contract with the Premier Healthcare Alliance for its IrriSept® wound debridement and cleansing system. The system is the first and only FDA-cleared irrigation de IrriMax® Corporation, (Gainesville, FL), has been awarded a supplier contract with the Premier Healthcare Alliance for its IrriSept® wound debridement and cleansing system. The system is the first and only FDA-cleared irrigation device containing chlorhexidine gluconate (CHG), providing an alternative to traditional saline irrigation. It is packaged and available for use in surgical and nonsurgical environments.

  For more information, visit www.irrisept.com.

This article was not subject to the Ostomy Wound Management peer-review process.